Alzheimers Disease (AD) is a progressive neurodegenerative disorder that poses significant challenges in its early diagnosis, often leading to delayed treatment and poorer outcomes for patients. Traditional diagnostic methods, typically reliant on single data modalities, fall short of capturing the multifaceted nature of the disease. In this paper, we propose a novel multimodal framework for the early detection of AD that integrates data from three primary sources: MRI imaging, cognitive assessments, and biomarkers. This framework employs Convolutional Neural Networks (CNN) for analyzing MRI images and Long Short-Term Memory (LSTM) networks for processing cognitive and biomarker data. The system enhances diagnostic accuracy and reliability by aggregating results from these distinct modalities using advanced techniques like weighted averaging, even in incomplete data. The multimodal approach not only improves the robustness of the detection process but also enables the identification of AD at its earliest stages, offering a significant advantage over conventional methods. The integration of biomarkers and cognitive tests is particularly crucial, as these can detect Alzheimer's long before the onset of clinical symptoms, thereby facilitating earlier intervention and potentially altering the course of the disease. This research demonstrates that the proposed framework has the potential to revolutionize the early detection of AD, paving the way for more timely and effective treatments

Introduction. We investigate the generalization ability of models built on datasets containing a small number of subjects, recorded in single study protocols. Next, we propose and evaluate methods combining these datasets into a single, large dataset. Finally, we propose and evaluate the use of ensemble techniques by combining gradient boosting with an artificial neural network to measure predictive power on new, unseen data. Methods. Sensor biomarker data from six public datasets were utilized in this study. To test model generalization, we developed a gradient boosting model trained on one dataset (SWELL), and tested its predictive power on two datasets previously used in other studies (WESAD, NEURO). Next, we merged four small datasets, i.e. (SWELL, NEURO, WESAD, UBFC-Phys), to provide a combined total of 99 subjects,. In addition, we utilized random sampling combined with another dataset (EXAM) to build a larger training dataset consisting of 200 synthesized subjects,. Finally, we developed an ensemble model that combines our gradient boosting model with an artificial neural network, and tested it on two additional, unseen publicly available stress datasets (WESAD and Toadstool). Results. Our method delivers a robust stress measurement system capable of achieving 85% predictive accuracy on new, unseen validation data, achieving a 25% performance improvement over single models trained on small datasets. Conclusion. Models trained on small, single study protocol datasets do not generalize well for use on new, unseen data and lack statistical power. Ma-chine learning models trained on a dataset containing a larger number of varied study subjects capture physiological variance better, resulting in more robust stress detection.

Introduction. The stress response has both subjective, psychological and objectively measurable, biological components. Both of them can be expressed differently from person to person, complicating the development of a generic stress measurement model. This is further compounded by the lack of large, labeled datasets that can be utilized to build machine learning models for accurately detecting periods and levels of stress. The aim of this review is to provide an overview of the current state of stress detection and monitoring using wearable devices, and where applicable, machine learning techniques utilized. Methods. This study reviewed published works contributing and/or using datasets designed for detecting stress and their associated machine learning methods, with a systematic review and meta-analysis of those that utilized wearable sensor data as stress biomarkers. The electronic databases of Google Scholar, Crossref, DOAJ and PubMed were searched for relevant articles and a total of 24 articles were identified and included in the final analysis. The reviewed works were synthesized into three categories of publicly available stress datasets, machine learning, and future research directions. Results. A wide variety of study-specific test and measurement protocols were noted in the literature. A number of public datasets were identified that are labeled for stress detection. In addition, we discuss that previous works show shortcomings in areas such as their labeling protocols, lack of statistical power, validity of stress biomarkers, and generalization ability. Conclusion. Generalization of existing machine learning models still require further study, and research in this area will continue to provide improvements as newer and more substantial datasets become available for study.

In many applications, different populations are compared using data that are sampled in a biased manner. Under sampling biases, standard methods that estimate the difference between the population means yield unreliable inferences. Here we develop an inference method that is resilient to sampling biases and is able to control the false positive errors under moderate bias levels in contrast to the standard approach. We demonstrate the method using synthetic and real biomarker data.

It may sound like the premise of a science fiction film. But, believe it or not, scientists at Boston University claim to have discovered a game-changing blood test that could help predict lifespans. The study, published in the journal Aging Cell on Friday, used biomarker data collected from 5,000 blood samples and analysed it against the donors' health developments over the subsequent eight years. Together, they identified patterns which indicated both good and bad futures. In all, the researchers generated 26 different predictive biomarker signatures.